Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. 1991

V L Tybulewicz, and C E Crawford, and P K Jackson, and R T Bronson, and R C Mulligan
Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142.

The c-abl proto-oncogene, which encodes a cytoplasmic protein-tyrosine kinase, is expressed throughout murine gestation and ubiquitously in adult mouse tissues. However, its levels are highest in thymus, spleen, and testes. To examine the in vivo role of c-abl, the gene was disrupted in embryonic stem cells, and the resulting genetically modified cells were used to establish a mouse strain carrying the mutation. Most mice homozygous for the c-abl mutation became runted and died 1 to 2 weeks after birth. In addition, many showed thymic and splenic atrophy and a T and B cell lymphopenia.

UI MeSH Term Description Entries
D008231 Lymphopenia Reduction in the number of lymphocytes. Lymphocytopenia,Lymphocytopenias,Lymphopenias
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D005804 Genes, Lethal Genes whose loss of function or gain of function MUTATION leads to the death of the carrier prior to maturity. They may be essential genes (GENES, ESSENTIAL) required for viability, or genes which cause a block of function of an essential gene at a time when the essential gene function is required for viability. Alleles, Lethal,Allele, Lethal,Gene, Lethal,Lethal Allele,Lethal Alleles,Lethal Gene,Lethal Genes
D005818 Genetic Engineering Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc. Genetic Intervention,Engineering, Genetic,Intervention, Genetic,Genetic Interventions,Interventions, Genetic
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes

Related Publications

V L Tybulewicz, and C E Crawford, and P K Jackson, and R T Bronson, and R C Mulligan
February 1985, Biochimica et biophysica acta,
V L Tybulewicz, and C E Crawford, and P K Jackson, and R T Bronson, and R C Mulligan
December 1982, Science (New York, N.Y.),
V L Tybulewicz, and C E Crawford, and P K Jackson, and R T Bronson, and R C Mulligan
February 1991, Cell,
V L Tybulewicz, and C E Crawford, and P K Jackson, and R T Bronson, and R C Mulligan
January 1993, Development (Cambridge, England),
V L Tybulewicz, and C E Crawford, and P K Jackson, and R T Bronson, and R C Mulligan
May 1988, Zhonghua zhong liu za zhi [Chinese journal of oncology],
V L Tybulewicz, and C E Crawford, and P K Jackson, and R T Bronson, and R C Mulligan
February 1990, Leukemia,
V L Tybulewicz, and C E Crawford, and P K Jackson, and R T Bronson, and R C Mulligan
March 2010, Neoplasia (New York, N.Y.),
V L Tybulewicz, and C E Crawford, and P K Jackson, and R T Bronson, and R C Mulligan
February 1999, Molecular & general genetics : MGG,
V L Tybulewicz, and C E Crawford, and P K Jackson, and R T Bronson, and R C Mulligan
December 1992, Genes & development,
V L Tybulewicz, and C E Crawford, and P K Jackson, and R T Bronson, and R C Mulligan
April 1987, Brain research,
Copied contents to your clipboard!